Cover Image

AGIHO guideline on evidence-based management of COVID-19 in cancer patients: 2022 update on vaccination, pharmacological prophylaxis and therapy in light of the omicron variants

The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe infections, rendering prophylaxis and treatment strategies for these patients p...

Full description

Saved in:
Bibliographic Details
Main Authors: Giesen, Nicola (Author) , Busch, Elena (Author) , Schalk, Enrico (Author) , Beutel, Gernot (Author) , Rüthrich, Maria Madeleine (Author) , Hentrich, Marcus (Author) , Hertenstein, Bernd (Author) , Hirsch, Hans H. (Author) , Karthaus, Meinolf (Author) , Khodamoradi, Yascha (Author) , Köhler, Philipp (Author) , Krüger, William H. (Author) , Koldehoff, Michael (Author) , Krause, Robert (Author) , Mellinghoff, Sibylle Christiane (Author) , Penack, Olaf (Author) , Sandherr, Michael (Author) , Seggewiß-Bernhardt, Ruth (Author) , Spiekermann, Karsten (Author) , Sprute, Rosanne (Author) , Stemler, Jannik (Author) , Weißinger, Florian (Author) , Wörmann, Bernhard (Author) , Wolf, Hans-Heinrich (Author) , Cornely, Oliver Andreas (Author) , Rieger, Christina (Author) , Lilienfeld-Toal, Marie von (Author)
Format: Article (Journal)
Language:English
Published: 16 January 2023
In: European journal of cancer
Year: 2023, Volume: 181, Pages: 102-118
ISSN:1879-0852
DOI:10.1016/j.ejca.2022.11.030
Online Access:Resolving-System, kostenfrei: https://doi.org/10.1016/j.ejca.2022.11.030
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S0959804922017804
Get full text
Author Notes:Nicola Giesen, Elena Busch, Enrico Schalk, Gernot Beutel, Maria M. Rüthrich, Marcus Hentrich, Bernd Hertenstein, Hans H. Hirsch, Meinolf Karthaus, Yascha Khodamoradi, Philipp Koehler, William Krüger, Michael Koldehoff, Robert Krause, Sibylle C. Mellinghoff, Olaf Penack, Michael Sandherr, Ruth Seggewiss-Bernhardt, Karsten Spiekermann, Rosanne Sprute, Jannik Stemler, Florian Weissinger, Bernhard Wörmann, Hans-Heinrich Wolf, Oliver A. Cornely, Christina T. Rieger, Marie von Lilienfeld-Toal
Description
Summary:The novel coronavirus SARS-CoV-2 and the associated infectious disease COVID-19 pose a significant challenge to healthcare systems worldwide. Patients with cancer have been identified as a high-risk population for severe infections, rendering prophylaxis and treatment strategies for these patients particularly important. Rapidly evolving clinical research, resulting in the recent advent of various vaccines and therapeutic agents against COVID-19, offers new options to improve care and protection of cancer patients. However, ongoing epidemiological changes and rise of new virus variants require repeated revisions and adaptations of prophylaxis and treatment strategies to meet these new challenges. Therefore, this guideline provides an update on evidence-based recommendations with regard to vaccination, pharmacological prophylaxis and treatment of COVID-19 in cancer patients in light of the currently dominant omicron variants. It was developed by an expert panel of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical Oncology (DGHO) based on a critical review of the most recent available data.
Item Description:Online verfügbar 10. Dezember 2022, Artikelversion März 2023
Gesehen am 06.04.2023
Physical Description:Online Resource
ISSN:1879-0852
DOI:10.1016/j.ejca.2022.11.030

Similar Items